| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 186 | 2018 |
| Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies D Wilson, G Ambler, KJ Lee, JS Lim, M Shiozawa, M Koga, L Li, ... The Lancet Neurology 18 (7), 653-665, 2019 | 178 | 2019 |
| Ischemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation DJ Seiffge, GM De Marchis, M Koga, M Paciaroni, D Wilson, M Cappellari, ... Annals of neurology 87 (5), 677-687, 2020 | 162 | 2020 |
| Early start of DOAC after ischemic stroke: risk of intracranial hemorrhage and recurrent events DJ Seiffge, C Traenka, A Polymeris, L Hert, N Peters, P Lyrer, ST Engelter, ... Neurology 87 (18), 1856-1862, 2016 | 129 | 2016 |
| Development and validation of a prognostic model of swallowing recovery and enteral tube feeding after ischemic stroke M Galovic, AJ Stauber, N Leisi, W Krammer, F Brugger, J Vehoff, ... JAMA neurology 76 (5), 561-570, 2019 | 108 | 2019 |
| Reasons for prehospital delay in acute ischemic stroke J Fladt, N Meier, S Thilemann, A Polymeris, C Traenka, DJ Seiffge, ... Journal of the American Heart Association 8 (20), e013101, 2019 | 100 | 2019 |
| Causes and risk factors of cerebral ischemic events in patients with atrial fibrillation treated with non–vitamin K antagonist oral anticoagulants for stroke prevention M Paciaroni, G Agnelli, V Caso, G Silvestrelli, DJ Seiffge, S Engelter, ... Stroke, 2019 | 99 | 2019 |
| Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation DJ Seiffge, M Paciaroni, D Wilson, M Koga, K Macha, M Cappellari, ... Annals of neurology 85 (6), 823-834, 2019 | 98 | 2019 |
| Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial ST Engelter, C Traenka, H Gensicke, SA Schaedelin, AR Luft, ... The Lancet Neurology 20 (5), 341-350, 2021 | 96 | 2021 |
| Intravenous thrombolysis in patients with stroke taking rivaroxaban using drug specific plasma levels: experience with a standard operation procedure in clinical practice DJ Seiffge, C Traenka, AA Polymeris, S Thilemann, B Wagner, L Hert, ... Journal of stroke 19 (3), 347, 2017 | 69 | 2017 |
| Sex differences and functional outcome after intravenous thrombolysis FH Spaander, SM Zinkstok, IM Baharoglu, H Gensicke, A Polymeris, ... Stroke 48 (3), 699-703, 2017 | 63 | 2017 |
| Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants TR Meinel, D Wilson, H Gensicke, JF Scheitz, P Ringleb, I Goganau, ... JAMA neurology 80 (3), 233-243, 2023 | 56 | 2023 |
| Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation AA Polymeris, TR Meinel, H Oehler, K Hölscher, A Zietz, JF Scheitz, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (6), 588-598, 2022 | 55 | 2022 |
| Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage DJ Seiffge, G Kägi, P Michel, U Fischer, Y Béjot, S Wegener, M Zedde, ... Annals of neurology 83 (3), 451-459, 2018 | 55 | 2018 |
| Intravenous thrombolysis and platelet count H Gensicke, AS Al Sultan, D Strbian, C Hametner, SM Zinkstok, S Moulin, ... Neurology 90 (8), e690-e697, 2018 | 50 | 2018 |
| Recurrent ischemic stroke and bleeding in patients with atrial fibrillation who suffered an acute stroke while on treatment with nonvitamin K antagonist oral anticoagulants … M Paciaroni, V Caso, G Agnelli, MG Mosconi, M Giustozzi, DJ Seiffge, ... Stroke 53 (8), 2620-2627, 2022 | 47 | 2022 |
| Feasibility of rapid measurement of rivaroxaban plasma levels in patients with acute stroke DJ Seiffge, C Traenka, A Polymeris, L Hert, U Fisch, N Peters, ... Journal of thrombosis and thrombolysis 43, 112-116, 2017 | 47 | 2017 |
| Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or … JG Best, G Ambler, D Wilson, KJ Lee, JS Lim, M Shiozawa, M Koga, L Li, ... The Lancet Neurology 20 (4), 294-303, 2021 | 46 | 2021 |
| Association of prestroke metformin use, stroke severity, and thrombolysis outcome LP Westphal, R Widmer, U Held, K Steigmiller, C Hametner, P Ringleb, ... Neurology 95 (4), e362-e373, 2020 | 46 | 2020 |
| Practical “1-2-3-4-day” rule for starting direct oral anticoagulants after ischemic stroke with atrial fibrillation: combined hospital-based cohort study S Kimura, K Toyoda, S Yoshimura, K Minematsu, M Yasaka, M Paciaroni, ... Stroke 53 (5), 1540-1549, 2022 | 42 | 2022 |
